Shanghai RAAS Blood Products Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2024: 6.87%

Shanghai RAAS Blood Products Co., Ltd. Return on Equity (ROE) is 6.87% for the year ending December 31, 2024, a 14.41% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Shanghai RAAS Blood Products Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2023 was 6.00%, a -7.96% change year over year.
  • Shanghai RAAS Blood Products Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2022 was 6.52%, a 30.54% change year over year.
  • Shanghai RAAS Blood Products Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2021 was 5.00%, a -5.15% change year over year.
  • Shanghai RAAS Blood Products Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2020 was 5.27%, a -0.51% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share